Literature DB >> 11387182

Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care.

M Moher1, P Yudkin, L Wright, R Turner, A Fuller, T Schofield, D Mant.   

Abstract

OBJECTIVE: To assess the effectiveness of three different methods of promoting secondary prevention of coronary heart disease in primary care.
DESIGN: Pragmatic, unblinded, cluster randomised controlled trial.
SETTING: Warwickshire.
SUBJECTS: 21 general practices received intervention; outcome measured in 1906 patients aged 55-75 years with established coronary heart disease.
INTERVENTIONS: Audit of notes with summary feedback to primary health care team (audit group); assistance with setting up a disease register and systematic recall of patients to general practitioner (GP recall group); assistance with setting up a disease register and systematic recall of patients to a nurse led clinic (nurse recall group). MAIN OUTCOME MEASURES: At 18 months' follow up: adequate assessment (defined) of 3 risk factors (blood pressure, cholesterol, and smoking status); prescribing of hypotensive agents, lipid lowering drugs, and antiplatelet drugs; blood pressure, serum cholesterol level, and plasma cotinine levels.
RESULTS: Adequate assessment of all 3 risk factors was much more common in the nurse and GP recall groups (85%, 76%) than the audit group (52%). The advantage in the nurse recall compared with the audit group was 33% (95% confidence interval 19% to 46%); in the GP recall group compared with the audit group 23% (10% to 36%), and in the nurse recall group compared with the GP recall group 9% (-3% to 22%). However, these differences in assessment were not reflected in clinical outcomes. Mean blood pressure (148/80, 147/81, 148/81 mm Hg), total cholesterol (5.4, 5.5, 5.5 mmol/l), and cotinine levels (% probable smokers 17%, 16%, 19%) varied little between the nurse recall, GP recall, and audit groups respectively, as did prescribing of hypotensive and lipid lowering agents. Prescribing of antiplatelet drugs was higher in the nurse recall group (85%) than the GP recall or audit groups (80%, 74%). After adjustment for baseline levels, the advantage in the nurse recall group compared with the audit group was 10% (3% to 17%), in the nurse recall group compared with the GP recall group 8% (1% to 15%) and in the GP recall group compared with the audit group 2% (-6% to 10%).
CONCLUSIONS: Setting up a register and recall system improved patient assessment at 18 months' follow up but was not consistently better than audit alone in improving treatment or risk factor levels. Understanding the reasons for this is the key next step in improving the quality of care of patients with coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11387182      PMCID: PMC32168          DOI: 10.1136/bmj.322.7298.1338

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  22 in total

1.  Designing trials of interventions to change professional practice in primary care: lessons from an exploratory study of two change strategies.

Authors:  S Rogers; C Humphrey; I Nazareth; S Lister; Z Tomlin; A Haines
Journal:  BMJ       Date:  2000-06-10

2.  Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action).

Authors:  M Campbell; J Grimshaw; N Steen
Journal:  J Health Serv Res Policy       Date:  2000-01

3.  An assessment of morbidity registers for coronary heart disease in primary care. ASSIST (ASSessment of Implementation STrategy) trial collaborative group.

Authors:  M Moher; P Yudkin; R Turner; T Schofield; D Mant
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

Review 4.  Randomised controlled trials in primary care: case study.

Authors:  S Wilson; B C Delaney; A Roalfe; L Roberts; V Redman; A M Wearn; F D Hobbs
Journal:  BMJ       Date:  2000-07-01

5.  Analysis of a cluster randomized trial with binary outcome data using a multi-level model.

Authors:  R Z Omar; S G Thompson
Journal:  Stat Med       Date:  2000-10-15       Impact factor: 2.373

6.  Randomization by cluster. Sample size requirements and analysis.

Authors:  A Donner; N Birkett; C Buck
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

7.  A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

Authors:  T J Bowker; T C Clayton; J Ingham; N R McLennan; H L Hobson; S D Pyke; B Schofield; D A Wood
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

8.  Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study.

Authors:  A G Shaper; S J Pocock; M Walker; A N Phillips; T P Whitehead; P W Macfarlane
Journal:  J Epidemiol Community Health       Date:  1985-09       Impact factor: 3.710

9.  Assessment of function in routine clinical practice: description of the COOP Chart method and preliminary findings.

Authors:  E Nelson; J Wasson; J Kirk; A Keller; D Clark; A Dietrich; A Stewart; M Zubkoff
Journal:  J Chronic Dis       Date:  1987

10.  Comparison of tests used to distinguish smokers from nonsmokers.

Authors:  M J Jarvis; H Tunstall-Pedoe; C Feyerabend; C Vesey; Y Saloojee
Journal:  Am J Public Health       Date:  1987-11       Impact factor: 9.308

View more
  47 in total

1.  Updating guidelines on stable angina.

Authors:  T Lancaster; M Moher
Journal:  BMJ       Date:  2001-11-24

2.  Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial.

Authors:  Julia Langham; Helen Tucker; David Sloan; Jane Pettifer; Simon Thom; Harry Hemingway
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

Review 3.  Secondary prevention clinics: improving quality of life and outcome.

Authors:  N C Campbell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

4.  CONSORT statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2004-03-20

Review 5.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

6.  Barriers to detecting and treating hypercholesterolaemia in patients with ischaemic heart disease: primary care perceptions.

Authors:  James Hickling; Stephen Rogers; Irwin Nazareth
Journal:  Br J Gen Pract       Date:  2005-07       Impact factor: 5.386

Review 7.  Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback.

Authors:  Gro Jamtvedt; Jane M Young; Doris T Kristoffersen; Mary Ann O'Brien; Andrew D Oxman
Journal:  Qual Saf Health Care       Date:  2006-12

8.  eComment. Nurse-led clinics and cost-effectiveness.

Authors:  Narcis Hudorovic; Visnja Vicic-Hudorovic
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06

9.  Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial.

Authors:  James P Raftery; Guiqing L Yao; Peter Murchie; Neil C Campbell; Lewis D Ritchie
Journal:  BMJ       Date:  2005-02-16

10.  Secondary prevention of coronary heart disease in primary health care.

Authors:  Olivera Batić-Mujanović; Muharem Zildzić; Azijada Beganlić
Journal:  Bosn J Basic Med Sci       Date:  2006-05       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.